RG3039 Improves Survival In Two SMA Mouse Models dne June 05, 2013 Repligen RG3039 spinal muscular atrophy spinal muscular atrophy cure spinal muscular atrophy research +
Repligen RG3039 Now in Phase 1b Trial dne October 06, 2012 Quinazoline Repligen RG3039 spinal muscular atrophy cure spinal muscular atrophy research +
Repligen's Drug Successful in Phase 1 Study dne April 27, 2012 Quinazoline495 Repligen RG3039 spinal muscular atrophy spinal muscular atrophy cure spinal muscular atrophy research +
Repligen reports no adverse effects in phase 1 clinical study so far dne October 30, 2011 Quinazoline Repligen RG3039 spinal muscular atrophy cure spinal muscular atrophy research +